会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 98. 发明申请
    • Method for composite cell-based implants
    • 基于复合细胞的植入物的方法
    • US20040117033A1
    • 2004-06-17
    • US10731366
    • 2003-12-09
    • Carmelita G. FrondozaDavid S. HungerfordAlan H. ShikaniAbraham J. DombDavid J. FinkLeonard Bloom
    • A61F002/02
    • A61L27/3817A61F2/08A61K9/0024A61K9/1652A61K9/5036A61K35/12A61K47/36A61L27/3633A61L27/3641A61L27/3804A61L27/3813A61L27/3839A61L27/3852C08B15/005C08B33/00C08B37/00C08B37/0021C08B37/006C08H1/00C08J3/12C08J2305/08C12N5/0075C12N5/0654C12N5/0655C12N2500/02C12N2531/00C12N2533/70C12N2533/72
    • This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component. For example, the solid implant may result from the culturing of chondrocytes on microcarriers or scaffolds, thereby resulting in an implant having cartilage-like properties, whereas the injectable cells or aggregates may result from the culturing of stem cells, resulting thereby in cells capable of producing cells of a chondrogenic, fibroblastic, myoblastic or osteoblastic phenotype. In this example, cells in the injectable aggregates may promote the fixation to or rapid integration of the solid cartilage implant into surrounding cartilage, connective tissue, muscle or bone, respectively.
    • 本发明是用于植入细胞或细胞 - 微载体聚集体的组合的方法,其中一个组分包含固体可植入构建体,第二组分包含可注射制剂。 例如,在一个实施例中,可以首先植入固体植入物以填充接收植入物的空腔的大部分,然后填充可注射形式的细胞或细胞 - 微载体聚集体,伴随或不添加胶凝材料以促进快速凝胶化 原位可以注入到固体植入物周围的空间中,以将固体植入物固定在部位中和/或促进固体植入物与周围组织的快速粘附和/或整合。 在该实施方案中也考虑到可注射组分的细胞组成可能不同于固体组分。 例如,固体植入物可以由微载体或支架上的软骨细胞的培养产生,从而导致具有软骨样特性的植入物,而可注射细胞或聚集体可能是由培养干细胞导致的,从而导致能够 产生软骨形成,成纤维细胞,成肌细胞或成骨细胞表型的细胞。 在该实施例中,可注射聚集体中的细胞可以促进将固体软骨植入物固定或者快速整合到周围软骨,结缔组织,肌肉或骨骼中。
    • 99. 发明授权
    • Polysaccharides substituted with polycarboxylated moieties
    • 被多羧基部分取代的多糖
    • US5770711A
    • 1998-06-23
    • US723799
    • 1996-09-30
    • Sharon Linda GreeneRosann Marie KaylorKenneth Raymond Smith
    • Sharon Linda GreeneRosann Marie KaylorKenneth Raymond Smith
    • A61L15/28A61L15/62C08B11/12C08B15/00D06M13/11D06M13/192D21C9/00D21H11/20C08B15/10C08B37/00D21H13/04
    • D21H11/20A61L15/28A61L15/62C08B11/12C08B15/005D06M13/11D06M13/192D21C9/005
    • A derivatized polysaccharide in which at least a portion of the active hydrogens originally present in the polysaccharide are substituted by monovalent aliphatic groups containing at least two carboxylic acid groups to an extent sufficient to provide a degree of substitution of at least about 0.1. The monovalent aliphatic groups contain from 4 to about 10 carbon atoms. The polysaccharide may be cellulose. At least a portion of the carboxylic acid groups present in the derivatized polysaccharide may be crosslinked permanently or reversibly. The monovalent aliphatic groups containing at least two carboxylic acid groups may be derived from 2,3-epoxysuccinic acid; 1,2-epoxypropane-1,2,3-tricarboxylic acid; 2-(epoxyethyl)-succinic acid; or mixtures thereof. Also provided is a method of preparing a derivatized polysaccharide. The method involves providing a polysaccharide; dispersing the polysaccharide in a strongly alkaline aqueous alcohol solution; adding to the dispersion an excess of an aliphatic polycarboxylic acid having an epoxy group, wherein the aliphatic polycarboxylic acid contains from 4 to about 10 carbon atoms; and heating the dispersion at a temperature and for a time sufficient to permit the reaction of epoxy groups of the aliphatic polycarboxylic acid with active hydrogens present in the polysaccharide to an extent sufficient to result in a degree of substitution of at least about 0.1. The present invention further provides a paper containing an amount of the derivatized cellulose described above sufficient to provide improved strength characteristics to the paper, compared with an otherwise identical paper which lacks the derivatized cellulose.
    • 最初存在于多糖中的活性氢的至少一部分被含有至少两个羧酸基团的一价脂族基团取代至足以提供至少约0.1的取代度的衍生多糖。 一价脂族基团含有4至约10个碳原子。 多糖可以是纤维素。 存在于衍生化多糖中的羧酸基团的至少一部分可以永久地或可逆地交联。 含有至少两个羧酸基团的一价脂族基团可以衍生自2,3-环氧琥珀酸; 1,2-环氧丙烷-1,2,3-三羧酸; 2-(环氧乙基) - 琥珀酸; 或其混合物。 还提供了制备衍生化多糖的方法。 该方法包括提供多糖; 将多糖分散在强碱性醇水溶液中; 向所述分散体中加入过量的具有环氧基的脂族多元羧酸,其中所述脂肪族多元羧酸含有4至约10个碳原子; 并在足以允许脂族多元羧酸的环氧基与多糖中存在的活性氢反应的温度和时间下加热分散体至足以导致至少约0.1的取代度的程度。 本发明还提供了一种含有上述衍生纤维素量的纸,足以与纸张相比提供改善的强度特性,与缺乏衍生纤维素的其它相同的纸相比。
    • 100. 发明授权
    • Method of carrying out electrophoresis with a submerged gel
    • 用浸没凝胶进行电泳的方法
    • US5767196A
    • 1998-06-16
    • US579272
    • 1995-12-27
    • Branko Kozulic
    • Branko Kozulic
    • B01D57/02C07K1/26C08B15/00C08B31/00C08B37/00C08B37/12C08J3/24G01N27/447G01N27/26
    • C08J3/24B01D57/02C08B15/005C08B31/003C08B37/00G01N27/44747C08J2301/00C08J2305/00
    • A method of gel electrophoresis carried out in a submerged gel mode in which the gel is a bed of water insoluble, transparent, cross linked gel, which has been formed by: dissolving a polysaccharide, including at least one linear polysaccharide such as agarose or hydroxyethyl cellulose, in a suitable solvent, such as water; adding a cross linking agent, which is not charged nor becomes charged upon contact with water in a pH in the range of about 2 to 11, to the solution; and incubating this mixture in a quiescent state to substantially simultaneously react the polysaccharide and the cross linking agent and to gel the reaction product into a bed. The polysaccharide is at least one linear polysaccharides, but that linear polysaccharide may also be admixed with other linear polysaccharides and/or at least one non-linear polysaccharide. Synthetic organic polymers may also be admixed in the cross linking reaction mixture. The polysaccharide, and/or other polymers in the cross linking reaction mixture may be charged but are preferably uncharged, but if charged, the charge must be low enough so that the charge of the resulting gel, if any, will not interfere with the use of the gel to support an electrophoresis process carried out in a submerged gel mode. When the linear polysaccharide is agarose, the gel has improved elasticity and transparency.
    • 一种以浸没凝胶模式进行的凝胶电泳方法,其中凝胶是水不溶性,透明的交联凝胶床,其通过以下形成:将多糖包括至少一种线性多糖如琼脂糖或羟乙基 纤维素,在合适的溶剂如水中; 加入交联剂,其在约2至11的pH范围内与水接触时不带电,也不会与溶液充电; 并将该混合物在静止状态下孵育以基本上同时使多糖和交联剂反应并将反应产物凝胶化成床。 多糖是至少一种线性多糖,但也可以将线性多糖与其它线性多糖和/或至少一种非线性多糖混合。 合成的有机聚合物也可以在交联反应混合物中混合。 可以将交联反应混合物中的多糖和/或其它聚合物加入,但优选不带电荷,但如果加入,则电荷必须足够低,使得所得凝胶的电荷(如果有的话)将不会干扰使用 的凝胶以支持以浸没凝胶模式进行的电泳过程。 当线性多糖是琼脂糖时,凝胶具有改善的弹性和透明度。